| Program
2006 January 17
Dr. Willem J.M. Mulder
Department of Biomedical Engineering, Eindhoven University of Technology.
'MR imaging of neovasculature and angiogenesis'
February 10 (14.00 h)
Dr. Jens Kroll
Tumor Biology Center, Freiburg, Germany
‘Functional analysis of vascular cells: Novel genetic models and novel
molecules’.
March 8 (15.00 h)
Dr. Jeroen Bakkers
Netherlands Institute for Developmental Biology (NIOB, Hubrecht Laboratory), Utrecht, The
Netherlands
‘Genetics of cardiovascular development using zebrafish’
April 27 (10.00 h, groene zaal UNS50)
Microsymposium 'Novel strategies of angiogenesis inhibition'
Dr. Roy Bicknell
Angiogenesis Laboratory, Cancer Research UK, Weatherall Institute of Molecular Medicine,
University of Oxford, UK.
'Identifying novel genes in endothelial biology and angiogenesis'
Dr. Martijn Gebbink
Department of Hematology,
Utrecht University, The Netherlands.
'Beta-sheets: linking amyloidosis and tumor inhibition?'
Drs. Judy van Beijnum
Angiogenesis Laboratory, Dept. of Pathology, Research Institute for Growth and Development
(GROW), Maastricht University.
'Therapeutic targeting of tumor endothelium'
May 31
Dr. Paolo Madeddu
Experimental Cardiovascular Medicine, Bristol Heart Institute, University of Bristol, UK
'Therapeutic Angiogenesis'
June 14
Dr. Mirjam G.A. oude Egbrink
Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM) Maastricht
University.
'Blood platelets and tumor angiogenesis'
September 15
Maastricht Symposium on Angiogenesis
‘Angiogenesis:
fundamental
and clinical perspectives’
Dr. R. Bjerkvig (Bergen, Norway)
Dr. T.L.M. ten Hagen (Rotterdam, The
Netherlands)
Dr. K. Alitalo (Helsinki, Finland)
Dr. N. Ferrara (San Francisco, USA)
Dr. H.M. Pinedo (Amsterdam, The
Netherlands)
Dr. V.L. Thijssen (Maastricht, The
Netherlands)
Dr. K.H. Mayo (minneapolis, USA)
Dr. J.C. Rodriguez-Manzaneque (Barcelona,
Spain)
Dr. J. Waltenberger (Maastricht, The
Netherlands)
November 10
Dr. Joyce Bischoff
Children’s
Hospital Boston, Harvard Medical School
'Endothelial
Progenitor Cells for Cardiovascular Tissue-Engineering’
November 23
Dr.
Angelo Corti
Tumor
Biology and Vascular Targeting Unit, Department of Oncology, San
Raffaele Scientific Institute, Milan, Italy
'Targeting
tumor vasculature with NGR-modified cytokines’
|
